Daptomycin Is Effective for Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus epidermidis
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
This study evaluated the daptomycin activity against two methicillin-resistant Staphylococcus epidermidis (MRSE) clinical isolates with different vancomycin susceptibilities: MRSE-375, with a vancomycin MIC of 2 μg/ml, and NRS6, a glycopeptide-intermediate S. epidermidis (GISE) strain with a vancomycin MIC of 8 μg/ml. The in vivo activity of daptomycin at two different doses (standard dose [SD-daptomycin], 6 mg/kg of body weight/day intravenously [i.v.]; high dose [HD-daptomycin], 10 mg/kg/day i.v.) was evaluated in a rabbit model of infective endocarditis and compared with that of a standard dose of vancomycin (SD-vancomycin; 1 g i.v. every 12 h) for 2 days. For the MRSE-375 strain, high-dose vancomycin (HD-vancomycin; 1 g i.v. every 6 h) was also studied. For MRSE-375, SD- and HD-daptomycin therapy sterilized significantly more vegetations than SD-vancomycin therapy (9/15 [60%] and 11/15 [73%] vegetations, respectively, versus 3/16 [19%] vegetations; P = 0.02 and P = 0.002, respectively). HD-daptomycin sterilized more vegetations than HD-vancomycin (11/15 [73%] versus 5/15 [33%] vegetations; P = 0.03) and was more effective than SD- and HD-vancomycin in reducing the density of bacteria in valve vegetations (0 log 10 CFU/g vegetation [interquartile range {IQR}, 0 to 1 log 10 CFU/g vegetation] versus 2 log 10 CFU/g vegetation [IQR, 2 to 2 log 10 CFU/g vegetation] and 2 log 10 CFU/g vegetation [IQR, 0 to 2.8 log 10 CFU/g vegetation]; P = 0.002 and P = 0.01, respectively). For the NRS6 strain, SD- and HD-daptomycin were significantly more effective than vancomycin in reducing the density of bacteria in valve vegetations (3.7 log 10 CFU/g vegetation [IQR, 2 to 6 log 10 CFU/g vegetation] versus 7.1 log 10 CFU/g vegetation [IQR, 5.2 to 8.5 log 10 CFU/g vegetation]; P = 0.02). In all treatment arms, isolates recovered from vegetations remained susceptible to daptomycin and vancomycin and had the same MICs. In conclusion, daptomycin at doses of 6 mg/kg/day or 10 mg/kg/day is more effective than vancomycin for the treatment of experimental endocarditis due to MRSE and GISE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 1×
“These organisms are the most common etiologic agents of bacteremia among hospitalized patients, and Staphylococcus epidermidis is isolated from 50% to 70% of catheter-related bloodstream infections (3, 28).”
BackgroundMurdoch, D. R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.603 · Cited by 2,362
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795 · cited 10×
“ventional dosing and are not safe in humans (20, 22, 25).”
BackgroundMethodInfluentialBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577
Wootton, M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.4.399 · Cited by 414 · cited 1×
“aureus ATCC 700698 (Mu3) was used as a control strain (29).”
MethodEmergence of Coagulase-Negative Staphylococci as a Cause of Native Valve Endocarditis
Chu, V. H., Woods, C. W., Miro, J. M., Hoen, B., Cabell, C. H., Pappas, P. A., Federspiel, J., Athan, E., Stryjewski, M. E., Nacinovich, F., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/524666 · Cited by 187
Self-citationGavaldà, J., Torres, C., Tenorio, C., López, P., Zaragoza, M., Capdevila, J. A., Almirante, B., Ruiz, F., Borrell, N., Gomis, X., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.639 · Cited by 134
Chu, V. H., Miro, J. M., Hoen, B., Cabell, C. H., Pappas, P. A., Jones, P., Stryjewski, M. E., Anguera, I., Braun, S., Muñoz, P., et al. (2009) · Heart · doi:10.1136/hrt.2008.152975 · Cited by 109
Cited by
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Bae, I., Federspiel, J. J., Miró, J. M., Woods, C. W., Park, L., Rybak, M. J., Rude, T. H., Bradley, S., Bukovski, S., de la Maria, C. G., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/606027 · Cited by 122
Self-citationNannini, E. C., Singh, K. V., Arias, C. A., & Murray, B. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00856-13 · Cited by 64
Cervera, C., Castaneda, X., de la Maria, C. G., del Rio, A., Moreno, A., Soy, D., Pericas, J. M., Falces, C., Armero, Y., Almela, M., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu183 · Cited by 61
“of MRSA in vegetations between animals treated with the recommended doses of vancomycin and those treated with higher doses [18].”
BackgroundSelf-citation
Metadata
- Authors
- García-de-la-Mària, C., Marco, F., Armero, Y., Soy, D., Moreno, A., del Río, A., Almela, M., Cervera, C., Ninot, S., Falces, C., Mestres, C. A., Gatell, J. M., Jiménez de Anta, M. T., & Miró, J. M.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2010-07
- Volume
- 54
- Issue
- 7
- Pages
- 2781-2786
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2125725269
- Cited by
- 68
- References
- 10
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Daptomycin Is Effective for Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus epidermidis. https://app.cochat.ai/papers/10.1128/aac.01011-09
- The paper
- García-de-la-Mària, C., Marco, F., Armero, Y., Soy, D., Moreno, A., del Río, A., Almela, M., Cervera, C., Ninot, S., Falces, C., Mestres, C. A., Gatell, J. M., Jiménez de Anta, M. T., & Miró, J. M. (2010). Daptomycin Is Effective for Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01011-09
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.